SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-A

For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or (g) of the
Securities Exchange Act of 1934

CLINICHEM DEVELOPMENT INC.
DEVELOPPEMENT CLINICHEM INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

CANADA N/A

(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER IDENTIFICATION NO.)
INCORPORATION)

275 ARMAND-FRAPPIER BOULEVARD
LAVAL, QUEBEC, CANADA H7V 4A7
(514) 681-1744

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

IF THIS FORM RELATES TO THE REGISTRATION OF A CLASS OF SECURITIES PURSUANT TO
SECTION 12(b) OF THE EXCHANGE ACT AND IS EFFECTIVE PURSUANT TO GENERAL
INSTRUCTION A.(c), PLEASE CHECK THE FOLLOWING BOX. [ ]

IF THIS FORM RELATES TO THE REGISTRATION OF A CLASS OF SECURITIES PURSUANT TO
SECTION 12(g) OF THE EXCHANGE ACT AND IS EFFECTIVE PURSUANT TO GENERAL
INSTRUCTION A. (d), PLEASE CHECK THE FOLLOWING BOX. [ x ]

SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
NONE

SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
CLASS A COMMON SHARES, NO PAR VALUE
(TITLE OF CLASS)

2
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.

Incorporated by reference to the section entitled "Description of
CliniChem's Share Capital" contained on page 62 of the Prospectus filed with
the Securities and Exchange Commission on May 6, 1998 as part of the Registrant
s Amendment No. 3 to the Form F-1 Registration Statement (Registration No.
333-45871).

The Registrant has filed an application to list the Class A Common
Shares on the NASDAQ Stock Market ("NASDAQ"). This Form 8-A is being filed to
list the Class A Common Shares on NASDAQ.

ITEM 2. EXHIBITS.

The following exhibits are filed as a part of this registration
statement.

EXHIBIT
NUMBER DESCRIPTION OF EXHIBIT PAGE NO.
- ----------- ----------------------------------- ------------------------------------------------

2.1 Specimen of Class A Common Share Incorporated by reference to Exhibit 4.1 to
to be registered hereunder Registrant s Amendment No. 3 to the Form F-1
Registration Statement filed May 6, 1998
(Registration No. 333-45871).

2.2 Copies of constituent instruments Incorporated by reference to the Registrant's By-
defining the rights of the holders Laws and the Registrant s Articles of Amendment
of the security to be registered filed as Exhibits 3.2 and 3.3 to Registrant s
hereunder. Amendment No. 3 to the Form F-1 Registration
Statement filed May 6, 1998
(Registration No. 333-45871).

-2-
3

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized.

DATE: May 27, 1998 CLINICHEM DEVELOPMENT INC.

By:/s/ Charles-A. Tessier
-------------------------------
Charles-A. Tessier
General Counsel and Secretary

-3-